HOYA launches VisuPro advanced focus lenses to tackle early signs of presbyopia

Topical lipoic acid choline ester eye drop for improvement of near visual acuity in subjects with presbyopia: a safety and preliminary efficacy trial

This study evaluated the safety of topical lipoic acid choline ester (UNR844, 1.5%) ophthalmic solution and its efficacy in improving distance-corrected near visual acuity (DCNVA) in subjects with presbyopia. This was a prospective, randomized, double-masked, and multicentre clinical trial. Subjects with a diagnosis of presbyopia (n = 75) were randomized 2:1 to UNR844 or placebo. On days 1–7, all subjects were dosed unilaterally (twice a day, b.…

Advancing presbyopia treatment through optimized design

Understanding the precise formulation of pharmacologic agents for refractive correction for presbyopia.

HOYA launches VisuPro advanced focus lenses to tackle early signs of presbyopia

HOYA's new VisuPro All Day and VisuPro Flex spectacle lenses are designed to help younger people experiencing the first symptoms of presbyopia. Image: HOYA.HOYA Lens Australia & New Zealand has launched its VisuPro All Day and VisuPro Flex advanced focus spectacle lenses. A media release from the company said the lenses were targeted to help people in their late 30s to mid-40s who are beginning to experience the gradual loss of their eyes’ abili…